GSK

GSK R&D chief Vallance is out as its new CEO changes direction under a new crew
Endpoints
Fri, 11/3/17 - 10:40 am
GSK
R&D
restructuring
drug development
Pharma giant GSK to start booking Brexit costs by year-end
Belfast Telegraph, Ireland
Fri, 10/27/17 - 11:14 am
GSK
UK
Brexit
Sanofi, J&J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report
Fierce Pharma
Thu, 10/26/17 - 10:58 am
Sanofi
JNJ
GSK
Reckitt Benckiser
Pfizer
M&A
consumer health
OTC
GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?
Fierce Pharma
Wed, 10/25/17 - 10:13 pm
GSK
M&A
Pfizer
OTC
consumer health
With Advair copies looming, GSK keeps focus on new drugs
Biopharma Dive
Wed, 10/25/17 - 10:12 pm
GSK
earnings
Advair
Trelegy Ellipta
Shingrix
What’s driving the rapid growth of the top 20 biopharma companies in the world?
Endpoints
Wed, 10/25/17 - 11:24 am
JNJ
Roche
Pfizer
Novartis
Merck
Serono
AbbVie
Sanofi
Amgen
Bayer
GSK
GSK to study consumer health buys but pharma top priority
Yahoo/Reuters
Wed, 10/25/17 - 09:43 am
GSK
consumer health
M&A
Drugmaker GSK sees sales rise thanks to new products
Yahoo/AP
Wed, 10/25/17 - 09:41 am
GSK
earnings
GSK picks up NICE recommendation for Strimvelis, a €594,000 gene therapy
Fierce Pharma
Mon, 10/23/17 - 09:55 pm
GSK
NICE
UK
Strimvelis
gene therapy
ADA-SCID
Vaccine approval buoys GSK new drug push
Biopharma Dive
Mon, 10/23/17 - 09:48 pm
GSK
Shingrix
shingles
vaccines
Merck
Zostavax
What's next for biopharma Q3 earnings
Biopharma Dive
Sat, 10/21/17 - 09:50 pm
earnings
Amgen
Bristol-Myers Squibb
Celgene
GSK
Gilead Sciences
AbbVie
Merck
Shire
GlaxoSmithKline wins blockbuster green light with Shingrix, its new shingles vaccine
Fierce Pharma
Sat, 10/21/17 - 10:30 am
GSK
vaccines
shingles
FDA
Shingrix
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix
Fierce Pharma
Tue, 10/17/17 - 08:24 pm
GSK
vaccines
Shingrix
shingles
GlaxoSmithKline has been ranked the worst governed company on the FTSE 100
Topix
Tue, 10/10/17 - 11:17 pm
GSK
bribery
Small is big: Pharma’s R&D brain drain continues as GSK’s Chris Carpenter jumps to upstart Rubius
Endpoints
Wed, 09/27/17 - 11:57 am
GSK
R&D
Rubius
J&J lines up its 4-in-1 HIV pill for FDA behind rivals from Gilead, GSK
Endpoints
Mon, 09/25/17 - 09:44 am
JNJ
HIV
Gilead
GSK
FDA
D/C/F/TAF
GSK vets Witty and Slaoui find new roles in biotech as the great migration continues
Endpoints
Fri, 09/22/17 - 11:11 am
GSK
Andrew Witty
Moncef Slaoui
biotech
Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Fierce Pharma
Wed, 09/20/17 - 11:08 pm
Pfizer
GSK
Eli Lilly
emerging markets
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
Endpoints
Wed, 09/20/17 - 09:23 am
R&D
John Houston
Big Pharma
biotech
Arvinas
GSK
Bristol-Myers Squibb
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
Fierce Pharma
Tue, 09/19/17 - 10:21 pm
GSK
FDA
Trelegy Ellipta
COPD

Pages